St. Jude Commences Simultaneous Epic HF, Atlas+ HF CRT-D Launches

St. Jude Medical's entry into the cardiac resynchronization therapy (CRT) market will be supported by a 20% sales force expansion, from roughly 1,000 to 1,200 people this year

More from Archive

More from Medtech Insight